April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform for instant 3D medical image processing, review, and surgical planning, enabling commercialization in the United States.

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next-generation Ultreon 3.0 software. This marks a major step forward as it brings coronary imaging and AI-automated insights together in one system to support better patient outcomes and help reduce risks.

April 24, 2026 — The 2026 vacancy rate for radiation therapists decreased to 11.4% and the vacancy rate for medical dosimetrists decreased to 6.8%, according to the biennial ASRT Radiation Therapy Workplace and Staffing Survey. This is compared to a 13.6% vacancy rate for radiation therapists and 9.6% for medical dosimetrists reported in the 2024 staffing survey.   

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) contrast agent, mangaciclanol, at Mayo Clinic in Rochester, Minnesota.

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a fully integrated AI operating environment designed to enable healthcare providers to deploy, manage and scale clinical AI as a unified system.

April 20, 2026 — Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in medical imaging through the signing of a multi-year Master Research Agreement (MRA). By combining resources, scientific capabilities and complementary expertise, the collaboration aims to accelerate the development and optimization of advanced imaging technologies, enhancing clinical insights and contributing to improved patient management.

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc., "to further the innovation, commercialization and adoption of advanced AI-powered mammography tools." 

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral CT Verida system, bringing its next-generation, AI-powered spectral CT innovation to the United States.

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with Olea Medical, a provider of advanced imaging software solutions.The QT Imaging-Olea Viewer provides a unified platform for viewing multiple breast imaging modalities, enabling clinicians to efficiently correlate findings across imaging sources and monitor patients longitudinally. By reducing reliance on multiple software viewers, the system streamlines workflow, enhances clinical efficiency, and supports more informed patient management over time.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now